Isomorphic Labs introduces further IsoDDE capabilities
Isomorphic Labs →Isomorphic Labs published an update on the Isomorphic Labs Drug Design Engine, or IsoDDE, describing a unified computational system that extends beyond structure prediction. The company highlighted protein-ligand structure prediction, small-molecule binding-affinity prediction, antibody-antigen modeling and identification of potential binding pockets. Its technical discussion describes benchmark results and examples involving structures unlike those used in training. These performance statements are the company’s reported research findings, not independent clinical validation or evidence of an approved medicine. Isomorphic said its drug-design teams use the system to study unseen structures, identify pockets and create chemical matter across research programs. The update links to a supporting technical report.